Sagent Pharmaceuticals Lands $40,000,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=489abbae-9276-4166-b63b-68eddfdc8033&Preview=1 - Date
4/9/2010 - Company Name
Sagent Pharmaceuticals - Mailing Address
1901 N. Roselle Road Schaumburg, IL 60195 - Company Description
SAGENT is a forward-thinking specialty injectables company that goes beyond just listening to what our customers have to say. We’re committed to responding to what we hear. With speed, with flexibility, and with efficiency. - Website
http://www.sagentpharma.com - Transaction Type
Venture Equity - Transaction Amount
$40,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Undisclosed
